Structural insights into the binding modes of lanreotide and pasireotide with somatostatin receptor 1
aKobilka Institute of Innovative Drug Discovery, School of Medicine, the Chinese University of Hong Kong, Shenzhen 518172, China
bNeurobiology Key Laboratory of Jining Medical University, Jining 272067, China
cShenzhen Futian Biomedical Innovation R&D Center, the Chinese University of Hong Kong, Shenzhen 518033, China
dThe Second Affiliated Hospital, School of Medicine, the Chinese University of Hong Kong, Shenzhen 518172, China
eWarwick Medical School, University of Warwick, Coventry CV47AL, United Kingdom
* Corresponding authors.
收起